
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.730 | 5.730 | 0.000 |
Shares | 94.530 | 94.530 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.998 | 22.347 |
Price to Book | 2.291 | 2.714 |
Price to Sales | 4.793 | 3.330 |
Price to Cash Flow | 17.737 | 16.400 |
Dividend Yield | 2.201 | 2.102 |
5 Years Earnings Growth | 6.349 | 6.822 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.560 | 97.797 |
Basic Materials | 2.390 | 0.472 |
Industrials | 0.030 | 0.563 |
Technology | 0.020 | 0.380 |
Number of long holdings: 129
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
WuXi AppTec | CNE1000031K4 | 9.63 | 77.15 | +9.99% | |
Changchun High A | CNE0000007J8 | 4.09 | 102.00 | +0.59% | |
Chongqing Zhifei Bio Products | CNE100000V20 | 4.02 | 20.54 | -0.24% | |
Hangzhou Tigermed Consulting | CNE100001KV8 | 3.62 | 59.51 | +2.82% | |
New Industries | CNE100003T39 | 3.55 | 55.19 | -0.56% | |
Imeik | CNE100004868 | 3.53 | 174.11 | +1.24% | |
Beijing Wantai Biological Pharmacy Enterprise Co | CNE100004090 | 3.41 | 59.50 | -0.70% | |
Pharmaron Beijing | CNE100003JW4 | 3.41 | 27.03 | +7.69% | |
Beijing Tiantan Bio | CNE000000WF9 | 3.11 | 19.66 | -0.20% | |
Walvax BioTech | CNE100000WN2 | 2.47 | 11.57 | +0.96% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund Blue Chip Selected Mixed | 38.91B | 0.83 | -9.82 | - | ||
E Fund Consumer Sector | 18.94B | -6.74 | -8.77 | 8.28 | ||
E Fund SSE50 Index | 18.94B | 0.11 | -3.37 | 5.43 | ||
E Fund CSI300 ETF Feeder Fund | 18.77B | 1.26 | -1.76 | 1.18 | ||
E Fund Mid Small Cap | 14.17B | 0.73 | -9.89 | 8.53 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review